BioCentury
ARTICLE | Emerging Company Profile

Pneumagen: out-competing viral sugar binding to prevent infection

Pneumagen targeting infections, cancer by co-opting and enhancing microbial carbohydrate binders

February 13, 2020 11:42 PM UTC

With its platform of carbohydrate-binding proteins, Pneumagen is co-opting a pathogenic tool for interacting with host cells to block infections and adapting the technology for use against cancer.

Both viruses and bacteria can interact with human cells via proteins that recognize sugar residues, including sialic acid, on proteoglycans...

BCIQ Company Profiles

Pneumagen Ltd.